Measurements of the DNA double-strand break response by Muslimovic, Aida
  Measurements of the DNA double-strand break 
response 
Akademisk avhandling 
som för avläggande av medicine doktorsexamen vid Sahlgrenska akademin 
vid Göteborgs Universitet kommer att offentligen försvaras i hörsal         
Arvid Carlsson, Medicinaregatan 3, Göteborg 
fredagen den 19 okt 2012 kl. 13 
av 
Aida Muslimović 
Fakultetsopponent: Professor, MD Qiang Pan-Hammarström         
Institutionen för Laboratoriemedicin, Avdelningen för Klinisk Immunologi 
och Transfusionsmedicin vid Karolinska Institutet 
 
Avhandlingen baseras på följande arbeten:  
I. Muslimović A, Nyström S, Gao Y, Hammarsten O. 
Numerical analysis of etoposide induced DNA breaks. PLoS 
ONE 2009 4(6):e5859. 
II. Muslimović A, Ismail IH, Gao Y, Hammarsten O. An 
optimized method for measurement of gamma-H2AX in 
blood mononuclear and cultured cells. Nat Protocols 2008 
3(7):1187-93. 
III. Muslimović A, Johansson P, Ruetschi U, Hammarsten O. 
Calibrators for clinical measurements of phosphorylated 
H2AX in patient cells by flow cytometry. Submitted 
Manuscript. 
IV. Johansson P, Muslimović A, Hultborn R, Fernström E, 
Hammarsten O. In-solution staining and arraying method 
from the immunofluorescence detection of γH2AX foci 
optimized for clinical applications. Biotechniques 2011 
51(3):185-9
Abstract 
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Medicine, The Sahlgrenska Academy at the University of Gothenburg 
Radiotherapy and some chemotherapeutic drugs kill cancer cells by induction of the 
extremely toxic DNA double-strand breaks (DSBs). Measurements of the DSB 
response in patients during therapy could allow personalized dosing to improve 
tumor response and minimize side effects. DSBs induce a strong cellular response via 
phosphorylation of H2AX, P-H2AX and the formation of foci. P-H2AX can be 
measured by flow cytometry or counted in separate cell nuclei by 
immunofluorescence microscopy. The overall aim of my research has been to 
develop and validate methods to measure P-H2AX in mononuclear cells from cancer 
patients undergoing radiotherapy.  
 Initially, we wanted to characterize DNA damage induced by the 
chemotherapeutic drug etoposide that induces TopoII-linked DSBs and to test its 
ability to activate the P-H2AX response using a flow cytometry-based P-H2AX 
assay. We found that only 0.3% of etoposide-induced DSBs activated the H2AX 
response and toxicity. We concluded that the P-H2AX response was a good measure 
of the toxic effects of etoposide.   
 Next, we wanted to optimize the flow cytometry assay for 
mononuclear cells from cancer patients undergoing radiation therapy. The P-H2AX 
response was measured before and after 5Gy pelvic irradiation and in in vitro-
irradiated controls. We found a fraction of cells with high P-H2AX signals that 
corresponded to the 5Gy in vitro-irradiated blood controls. This study indicated that 
flow cytometry may be well suited for measurements of the P-H2AX response in 
mononuclear cells following local radiotherapy.    
 To be able to implement the P-H2AX assay in clinical practice and 
use it in relation to clinical outcome and side effects we have also developed stable 
and reliable calibrators based on phosphopeptide-coated beads and fixed cells. Using 
these calibrators it could be possible to use the P-H2AX flow cytometry assay in the 
clinic in a controlled manner.    
 Finally, using immunostaining in solution before cells are mounted 
on microscopic slides for quantification of single P-H2AX foci by 
immunofluorescence, we have the possibility to analyze 16 patient samples within 
few hours, which makes this method suitable for clinical use. 
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